Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence

OBJECTIVE: To compare 1-year treatment adherence of ramipril + amlodipine and ramipril +hydroclorothiazide fixed-dose combination therapies in patients with hypertension. METHODS: Data were extracted from the database of the National Health Insurance Fund of Hungary. Treatment adherence was modelled...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonyi, Gábor, Ferenci, Tamás, Alföldi, Sándor, Farsang, Csaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536552/
https://www.ncbi.nlm.nih.gov/pubmed/27435392
http://dx.doi.org/10.1177/0300060516645004
_version_ 1783254031230042112
author Simonyi, Gábor
Ferenci, Tamás
Alföldi, Sándor
Farsang, Csaba
author_facet Simonyi, Gábor
Ferenci, Tamás
Alföldi, Sándor
Farsang, Csaba
author_sort Simonyi, Gábor
collection PubMed
description OBJECTIVE: To compare 1-year treatment adherence of ramipril + amlodipine and ramipril +hydroclorothiazide fixed-dose combination therapies in patients with hypertension. METHODS: Data were extracted from the database of the National Health Insurance Fund of Hungary. Treatment adherence was modelled using survival analysis. RESULTS: At 2 months after initiation of treatment, 42% of patients using ramipril +hydrochlorothiazide (n = 28,800) had discontinued treatment, compared with 0% of patients using ramipril + amlodipine (n = 10,295). At 1 year, treatment adherence was 29% in the ramipril + hydrochlorothiazide group and 54% in the ramipril + amlodipine group. The hazard ratio for discontinuing ramipril + hydrochlorothiazide vs ramipril + amlodipine was 2.318 (95% confidence intervals 2.246, 2.392). CONCLUSION: Ramipril + amlodipine had significantly higher 1-year treatment adherence than ramipril + hydrochlorothiazide in patients with hypertension.
format Online
Article
Text
id pubmed-5536552
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-55365522017-10-03 Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence Simonyi, Gábor Ferenci, Tamás Alföldi, Sándor Farsang, Csaba J Int Med Res Clinical Reports OBJECTIVE: To compare 1-year treatment adherence of ramipril + amlodipine and ramipril +hydroclorothiazide fixed-dose combination therapies in patients with hypertension. METHODS: Data were extracted from the database of the National Health Insurance Fund of Hungary. Treatment adherence was modelled using survival analysis. RESULTS: At 2 months after initiation of treatment, 42% of patients using ramipril +hydrochlorothiazide (n = 28,800) had discontinued treatment, compared with 0% of patients using ramipril + amlodipine (n = 10,295). At 1 year, treatment adherence was 29% in the ramipril + hydrochlorothiazide group and 54% in the ramipril + amlodipine group. The hazard ratio for discontinuing ramipril + hydrochlorothiazide vs ramipril + amlodipine was 2.318 (95% confidence intervals 2.246, 2.392). CONCLUSION: Ramipril + amlodipine had significantly higher 1-year treatment adherence than ramipril + hydrochlorothiazide in patients with hypertension. SAGE Publications 2016-07-19 2016-10 /pmc/articles/PMC5536552/ /pubmed/27435392 http://dx.doi.org/10.1177/0300060516645004 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Reports
Simonyi, Gábor
Ferenci, Tamás
Alföldi, Sándor
Farsang, Csaba
Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
title Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
title_full Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
title_fullStr Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
title_full_unstemmed Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
title_short Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
title_sort ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
topic Clinical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536552/
https://www.ncbi.nlm.nih.gov/pubmed/27435392
http://dx.doi.org/10.1177/0300060516645004
work_keys_str_mv AT simonyigabor ramiprilamlodipineandramiprilhydrochlorothiazidefixeddosecombinationsinrelationtopatientadherence
AT ferencitamas ramiprilamlodipineandramiprilhydrochlorothiazidefixeddosecombinationsinrelationtopatientadherence
AT alfoldisandor ramiprilamlodipineandramiprilhydrochlorothiazidefixeddosecombinationsinrelationtopatientadherence
AT farsangcsaba ramiprilamlodipineandramiprilhydrochlorothiazidefixeddosecombinationsinrelationtopatientadherence

Ejemplares similares